...
首页> 外文期刊>JAIDS: Journal of acquired immune deficiency syndromes >High-Risk Behavior and Potential Transmission of Drug-Resistant HIV Among Injection Drug Users.
【24h】

High-Risk Behavior and Potential Transmission of Drug-Resistant HIV Among Injection Drug Users.

机译:注射吸毒者中抗药性HIV的高危行为和潜在传播。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

: Evidence of increasing prevalence of drug resistance among recent HIV seroconverters indicates a growing public health concern and warrants an examination of the problem from a prevention perspective. Among 638 HIV-infected injection drug users (IDUs) completing 2731 visits between December 1996 and February 2000 in an ongoing cohort study in Baltimore, Maryland, factors associated with unprotected sex and needle sharing were determined. Participants were classified as being at higher or lower risk of HIV and of drug-resistant HIV transmission based on viral load, antiretroviral therapy use, and reported high-risk behavior. Stored plasma of those at higher risk of drug-resistant HIV transmission was tested for resistance by VirtualPhenotype (Vircolab, Rockville, MD). Women were nearly twice as likely as men to engage in unprotected sex, and IDUs were more likely to have unprotected sex if their sexual partners were also HIV infected. IDUs were at higher risk of HIV and drug-resistant HIV transmissionat 19% and 6% of all visits, respectively. Participants were infected with drug-resistant HIV at 14% of visits when they were at higher risk of HIV transmission. Intensive risk reduction counseling is needed and must be integrated into routine HIV clinical care.
机译::最近的HIV血清转化者中耐药性增加的证据表明公众对健康的关注与日俱增,因此有必要从预防的角度研究这一问题。在马里兰州巴尔的摩市进行的一项队列研究中,在1996年12月至2000年2月之间完成了2731次访问的638个HIV感染注射药物使用者(IDU)中,确定了与未保护性行为和共用针头相关的因素。根据病毒载量,抗逆转录病毒疗法的使用和报道的高风险行为,将参与者分为具有较高或较低的HIV风险和耐药HIV传播风险。已通过VirtualPhenotype(Vircolab,Rockville,MD)测试了具有较高抗药性HIV传播风险的患者血浆中的抗药性。妇女从事无保护性行为的可能性几乎是男性的两倍,而注射毒品使用者如果其性伴侣也感染了艾滋病毒,则更有可能遭受无保护的性行为。注射毒品使用者分别有19%和6%的人感染HIV和耐药性HIV的风险较高。参与者有较高的HIV传播风险时,有14%的访问者被抗药性HIV感染。需要加强降低风险的咨询,并且必须将其纳入常规的HIV临床护理中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号